Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Climb Bio, Inc. (CLYM)

NASDAQ

$15.52

$+0.94

(+6.44%)

Previous Close: ⁦$14.59⁩

Market Closed

Climb Bio, Inc. (CLYM) Live Price Chart

Last updated: ⁦2026-09-06 05:35:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Climb Bio, Inc. (CLYM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $15.52, with a market capitalisation of $864.42M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.54 to $18.33. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$864.42M
Open	$14.49
Day's High	$18.33
Day's Low	$1.05
Previous Close	$14.59
Volume	1.37M
Average Volume	--
P/E Ratio	--
52-Week High	$18.33
52-Week Low	$1.54
Dividend Yield	--
Earnings Date	--

Climb Bio, Inc. (CLYM) Latest Closing Stock Price

Climb Bio, Inc. (CLYM) last closed at $14.59 as of 2026-09-04 23:59:00, unchanged from the previous close of $14.59.

During the latest regular trading session, CLYM traded between $1.05 and $18.33, with a volume of 1.37M shares. The closing price was near the upper end and near the upper end of its 52-week range.

Climb Bio, Inc. (CLYM) 7-Day Stock Price Change

Over the past seven days, Climb Bio, Inc. (CLYM) moved from $14.58 to $15.52, representing a gain of 6.45% ($0.94).

The stock traded between $14.35 and $15.95 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 2.15 million shares, up versus the previous seven-day period, indicating higher trading activity.

CLYM 52-Week Price Position

Position in Range: 83.3%

52W Low$1.54

52W High$18.33

CLYM is currently trading at $15.52, placing it 83.3% of the way from its 52-week low of $1.54 to its 52-week high of $18.33. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Climb Bio, Inc. (CLYM)?

Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.

Climb Bio, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	29
Exchange	NASDAQ
Company Website	https://www.climbbio.com

How to Buy Climb Bio, Inc. (CLYM) Stock on MEXC

Eligible investors can buy real shares of Climb Bio, Inc. (CLYM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CLYM and Place Your Order

Open the RealStocks trading page and search for CLYM. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Climb Bio, Inc. (CLYM) share price today?

Climb Bio, Inc. (CLYM) is currently trading at $ 15.52, up 6.37% ($0.93) from the previous close of $ 14.59. Intraday prices update in real time during regular trading hours.

2.Is CLYM stock going up or down today?

As of 2026-09-04 23:59:00, CLYM is trading at $ 15.52, up 6.37% ($0.93) from its previous close of $ 14.59. The stock has traded between $ 1.05 and $ 18.33 during today’s regular session. Past price movements do not guarantee future results.

3.What is CLYM pre-market price?

As of 2026-09-04 23:59:00, CLYM is trading at $ 14.39 in pre-market trading, down 1.40% ($0.20) from the previous close of $ 14.59. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CLYM after-hours price?

As of 2026-09-04 23:59:00, CLYM is trading at $ 15.45 in after-hours trading, up 5.89% ($0.86) from the regular-session close of $ 14.59. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is CLYM stock trading now?

CLYM trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CLYM sit relative to its 52-week high and low?

Over the past 52 weeks, CLYM has traded between a low of $ 1.54 and a high of $ 18.33. At $ 15.52, the stock is positioned 83.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Climb Bio, Inc. in?

Climb Bio, Inc. (CLYM) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Climb Bio, Inc.'s market capitalisation and where is it listed?

Climb Bio, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 864.42M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CLYM valued in terms of P/E ratio and EPS?

CLYM trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.00. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Climb Bio, Inc. pay a dividend?

Climb Bio, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.